Analysts Viewpoint
A Guide To The Risks Of Investing In ATAI Life Sciences N.V (ATAI)
ATAI Life Sciences N.V’s filing revealed that its Chief Business Officer Kirpekar Sahil unloaded Company’s shares for reported $65560.0 on
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.